Jen Baird and her team at FifthEye were just granted De Novo classification by FDA for their Analytic for Hemodynamic Instability (AHI). AHI can continuously monitor any patient with an electrocardiogram (ECG) for hemodynamic instability. Come hear all about their success, what comes next for getting AHI to market, and what they've learned about working with FDA thus far!
